Curat Global LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,222 shares of the company's stock, valued at approximately $306,000.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Rothschild Investment LLC lifted its stake in Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company's stock valued at $101,000 after buying an additional 79 shares during the last quarter. CSS LLC IL lifted its stake in Cardinal Health by 0.8% in the fourth quarter. CSS LLC IL now owns 11,190 shares of the company's stock valued at $1,323,000 after buying an additional 90 shares during the last quarter. Private Trust Co. NA lifted its stake in Cardinal Health by 11.0% in the fourth quarter. Private Trust Co. NA now owns 930 shares of the company's stock valued at $110,000 after buying an additional 92 shares during the last quarter. Checchi Capital Advisers LLC lifted its stake in Cardinal Health by 2.7% in the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after buying an additional 93 shares during the last quarter. Finally, TIAA Trust National Association lifted its stake in Cardinal Health by 4.5% in the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock valued at $258,000 after buying an additional 94 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Cardinal Health Stock Up 0.4%
CAH stock traded up $0.56 on Friday, reaching $154.68. 959,422 shares of the company's stock were exchanged, compared to its average volume of 2,216,881. The stock has a fifty day moving average of $143.17 and a 200-day moving average of $131.18. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $157.82. The firm has a market cap of $36.92 billion, a PE ratio of 28.86, a P/E/G ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Cardinal Health's quarterly revenue was up .0% on a year-over-year basis. During the same quarter in the prior year, the company posted $2.08 earnings per share. On average, equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.32%. Cardinal Health's dividend payout ratio is 31.83%.
Analyst Ratings Changes
A number of brokerages have weighed in on CAH. Mizuho boosted their price objective on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Wells Fargo & Company upgraded Cardinal Health from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $136.00 to $179.00 in a research note on Tuesday. Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Robert W. Baird upped their price target on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research note on Friday, May 2nd. Finally, Bank of America upped their price target on Cardinal Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $149.50.
Get Our Latest Report on Cardinal Health
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
